Abstract:Objective To study the effect of melatonin on the expression of microRNA-9 (miRNA,miR-9) and the mechanism of melatonin reducing the inflammation in sepsis as well as the key role of miR-9 in inhibiting the inflammatory reaction in sepsis.Methods Sepsis mouse models were prepared and randomly divided into sepsis model group [lipopolysaccharide (LPS) group] and sepsis melatonin treatment group (Mel + LPS group).Melatonin (30 mg/kg,Mel + LPS group) or same volume of saline (Mel + LPS group) was administered half hour before LPS injection,at the same time of LPS injection and four hours after LPS injection intraperitoneally.Half of the mice were killed and blood was collected after 24 h.Remaining mice were killed 48 hours later.Tissues of liver,lung were collected and the pathological changes of the tissues were observed through hematoxylin and eosin (HE) staining.Protein levels of tumor necrosis factors (TNF)-α and interleukin (IL)-1β in serum were detected by enzyme-linked immunosorbent assay (ELISA) levels of miR-9 in lung and liver were detected by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR).RAW264.7 macrophages were divided into control inhibitor group (NC group),miR-9 inhibitor group (miR-9-in group),LPS + control inhibitor group (LPS + NC group) and LPS + miR-9 inhibitor group (LPS + miR-9-in group).Cells were transfected with miR-9 inhibitor,miR-9 inhibitor control section respectively.Levels of TNF-α and IL-1β were detected by FQ-PCR.Protein levels of p65 and p-p65 were detected by Western blotting.Results HE staining showed that organs in LPS group had severe damage and inflammatory cells infiltration.The degree of organ damage in Mel + LPS group was significantly improved compared with that in LPS group.Levels of TNF-α and IL-1β in Mel + LPS group were significantly decreased [TNF-α:(93.17 ± 21.92) ng/L vs.(236.83± 24.86) ng/L;IL-1β:(97.07± 14.62) ng/L vs.(159.63± 28.83) ng/L,P ＜0.01].In Mel + LPS group,levels of miR-9 in lung and liver were significantly decreased compared with those in LPS group (lung:0.61 ± 0.12 vs.2.36 ± 0.13;liver:0.62 ± 0.19 vs.2.85 ± 0.57,P ＜ 0.01).In macrophage,the levels of TNF-α,IL-13 in LPS + miR-9-in group significantly decreased (TNF-α:21.92 ± 3.67 vs.42.94 ± 8.88;IL-13:351.55 ± 71.89 vs.645.00 ± 55.02,P ＜ 0.01).The phosphorylated-p65 protein level was also decreased in LPS + miR-9-in group (0.14 ± 0.05 vs.0.67 ± 0.11,P ＜ 0.01).Conclusion Melatonin could inhibit the activation of the nuclear factor-κB (NF-κB) pathway by decreasing the level of miR-9,and finally suppress inflammation and organ damage in sepsis

Melatonin regulates inflammation in sepsis via microRNA-9 and related mechanism

MicroRNA‑129 Plays a Protective Role in Sepsis‑induced Acute Lung Injury Through the Suppression of Pulmonary Inflammation Via the Modulation of the TAK1/NF‑κB Pathway.

Altered melatonin secretion and circadian gene expression with increased proinflammatory cytokine expression in early-stage sepsis patients.

Disruption of the NF‐κB/NLRP3 connection by melatonin requires retinoid‐related orphan receptor‐α and blocks the septic response in mice

Methylation of miR‐19b‐3p promoter exacerbates inflammatory responses in sepsis‐induced ALI via targeting KLF7

Detection of melatonin protective effects in sepsis via argyrophilic nucleolar regulatory region‐associated protein synthesis and TLR4/NF‐κB signaling pathway

Short- and Long-Term Protective Effects of Melatonin in a Mouse Model of Sepsis-Associated Encephalopathy

Melatonin alleviates brain injury in mice subjected to cecal ligation and puncture via attenuating inflammation, apoptosis, and oxidative stress: the role of SIRT1 signaling

Melatonin alleviates sepsis-induced heart injury through activating the Nrf2 pathway and inhibiting the NLRP3 inflammasome

Melatonin Attenuates Sepsis-Induced Small-Intestine Injury by Upregulating SIRT3-Mediated Oxidative-Stress Inhibition, Mitochondrial Protection, and Autophagy Induction

microRNA-590-3p regulates inflammation and organ dysfunction in sepsis mouse model via the Syap1-mediated TGF-β/Smad signaling pathway

Melatonin Attenuates Neuroinflammation by Down-Regulating NLRP3 Inflammasome via a SIRT1-Dependent Pathway in MPTP-Induced Models of Parkinson's Disease

Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism

Melatonin Attenuates Sepsis-Induced Acute Lung Injury Through Improvement of Epithelial Sodium Channel-Mediated Alveolar Fluid Clearance Via Activation of SIRT1/SGK1/Nedd4-2 Signaling Pathway

Melatonin arrests excessive inflammatory response and apoptosis in lipopolysaccharide-damaged rat liver: A deeper insight into its mechanism of action

Melatonin Alleviates Acute Respiratory Distress Syndrome by Inhibiting Alveolar Macrophage NLRP3 Inflammasomes Through the ROS/HIF-1α/GLUT1 Pathway

Α-Mangostin Suppresses NLRP3 Inflammasome Activation Via Promoting Autophagy in LPS-stimulated Murine Macrophages and Protects Against CLP-induced Sepsis in Mice

A novel mechanism for the protection against acute lung injury by melatonin: mitochondrial quality control of lung epithelial cells is preserved through SIRT3-dependent deacetylation of SOD2

Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-κB, c/EBPβ, and p300 signaling

Inhibition of SIRT1 by Microrna-9, the Key Point in Process of LPS-induced Severe Inflammation

Protective Effects of Melatonin on Sepsis-Induced Liver Injury and Dysregulation of Gluconeogenesis in Rats Through Activating SIRT1/STAT3 Pathway.